BRPI1008037A2 - composição de espuma tópica - Google Patents

composição de espuma tópica

Info

Publication number
BRPI1008037A2
BRPI1008037A2 BRPI1008037A BRPI1008037A BRPI1008037A2 BR PI1008037 A2 BRPI1008037 A2 BR PI1008037A2 BR PI1008037 A BRPI1008037 A BR PI1008037A BR PI1008037 A BRPI1008037 A BR PI1008037A BR PI1008037 A2 BRPI1008037 A2 BR PI1008037A2
Authority
BR
Brazil
Prior art keywords
foam composition
topical foam
topical
composition
foam
Prior art date
Application number
BRPI1008037A
Other languages
English (en)
Inventor
Leon Loupenok
Original Assignee
Stiefel Res Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42664937&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1008037(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Stiefel Res Australia Pty Ltd filed Critical Stiefel Res Australia Pty Ltd
Publication of BRPI1008037A2 publication Critical patent/BRPI1008037A2/pt
Publication of BRPI1008037B1 publication Critical patent/BRPI1008037B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI1008037-6A 2009-02-25 2010-02-24 Composição de espuma aerossol de emulsão de óleo em água, uso da dita composição para o tratamento de uma doença, distúrbio ou condição da pele e processo para a preparação da dita composição BRPI1008037B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20240309P 2009-02-25 2009-02-25
US61/202.403 2009-02-25
PCT/AU2010/000213 WO2010096868A1 (en) 2009-02-25 2010-02-24 Topical foam composition

Publications (2)

Publication Number Publication Date
BRPI1008037A2 true BRPI1008037A2 (pt) 2016-03-15
BRPI1008037B1 BRPI1008037B1 (pt) 2019-08-06

Family

ID=42664937

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1008037-6A BRPI1008037B1 (pt) 2009-02-25 2010-02-24 Composição de espuma aerossol de emulsão de óleo em água, uso da dita composição para o tratamento de uma doença, distúrbio ou condição da pele e processo para a preparação da dita composição

Country Status (19)

Country Link
US (4) US10568859B2 (pt)
EP (1) EP2400951B1 (pt)
JP (2) JP6130992B2 (pt)
KR (1) KR101725196B1 (pt)
CN (1) CN102438590B (pt)
AU (1) AU2010217190B2 (pt)
BR (1) BRPI1008037B1 (pt)
CA (1) CA2753497C (pt)
CL (1) CL2011002053A1 (pt)
DK (1) DK2400951T3 (pt)
EA (1) EA020844B1 (pt)
ES (1) ES2696989T3 (pt)
IL (1) IL214520A (pt)
MX (1) MX340791B (pt)
PL (1) PL2400951T3 (pt)
PT (1) PT2400951T (pt)
SG (1) SG173563A1 (pt)
WO (1) WO2010096868A1 (pt)
ZA (1) ZA201105769B (pt)

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
EP2242476A2 (en) 2008-01-14 2010-10-27 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
PT2400951T (pt) * 2009-02-25 2018-11-26 Mayne Pharma Llc Composições de espuma tópica
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
JP5833007B2 (ja) 2009-08-31 2015-12-16 ドクター・レディーズ・ラボラトリーズ・リミテッド ステロイドを含む局所製剤
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
WO2011064631A1 (en) 2009-10-02 2011-06-03 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US8174881B2 (en) 2009-11-24 2012-05-08 Micron Technology, Inc. Techniques for reducing disturbance in a semiconductor device
PL2335675T3 (pl) 2009-12-10 2015-08-31 Neubourg Skin Care Gmbh & Co Kg Wolne od emulgatorów, stabilizowane polimerem formulacje pianki
US20220378671A1 (en) * 2010-03-02 2022-12-01 Neubourg Skin Care Gmbh & Co. Kg Foam Formulations Containing at Least One Triterpenoid
EP2363108B1 (de) * 2010-03-02 2017-08-30 Neubourg Skin Care GmbH & Co. KG Schaumformulierungen enthaltend mindestens ein Triterpenoid
US9636353B2 (en) 2010-10-21 2017-05-02 Cadila Healthcare Limited Method for treatment of acne using pharmaceutical compositions of clindamycin and adapalene
US10028972B2 (en) 2010-10-21 2018-07-24 Cadila Healthcare Limited Pharmaceutical compositions of anti-acne agents
WO2012053010A2 (en) * 2010-10-21 2012-04-26 Cadila Healthcare Limited Method for treatment of acne using pharmaceutical compositions of clindamycin
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
ES2645074T3 (es) 2011-03-03 2017-12-04 Cidara Therapeutics, Inc. Agentes antifúngicos y sus usos
GB201105050D0 (en) 2011-03-25 2011-05-11 Iiaa Ltd Pharmaceutical agent
DE102011018924A1 (de) 2011-04-28 2012-10-31 Tunap Industrie Chemie Gmbh & Co. Produktions Kg OW-Emulsionskonzentrat, Verfahren zu dessen Herstellung und dieses enthaltendes Hautkosmetikum
JP2014518265A (ja) * 2011-06-30 2014-07-28 アラーガン インコーポレイテッド レチノイド局所用組成物および皮膚疾病を治療するための方法
MX2011008984A (es) * 2011-08-25 2013-02-25 Genomma Lab Internacional S A B De C V Composicion para la administracion percutanea de compuestos activos que aseguran un tratamiento adecuado para la alopecia androgenetica.
US10232047B2 (en) 2011-12-20 2019-03-19 Vyome Biosciences Private Limited Topical oil composition for the treatment of fungal infections
RU2639483C2 (ru) 2012-03-19 2017-12-21 Сидара Терапьютикс, Инк. Режимы дозирования для соединений класса эхинокандинов
WO2013158319A1 (en) 2012-04-16 2013-10-24 Zemtsov Enterprises, Llc Formulations and methods for treatment of wounds and inflammatory skin conditions
PL2705847T3 (pl) * 2012-09-05 2015-02-27 Psoriasis Creams Sweden Ab Kompozycja do leczenia łuszczycy
US8778850B2 (en) * 2012-10-24 2014-07-15 Green Earth Technologies, Inc. Biodegradable non-reactive oil-well stimulation fluid and method of use
US20160058775A1 (en) * 2013-04-12 2016-03-03 Vyome Biosciences Pvt. Ltd. Composition and formulation of antimicrobial agents, processes thereof and methods for treating microbial infections
WO2015065132A1 (ko) * 2013-11-01 2015-05-07 엘지전자(주) 무선 통신 시스템에서 디스커버리 메시지를 전송하는 방법 및 이를 위한 장치
US20160184431A1 (en) 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
US9687455B2 (en) 2014-08-14 2017-06-27 John Daniel Dobak Sodium tetradecyl sulfate formulations for treatment of adipose tissue
US9351945B1 (en) 2015-02-27 2016-05-31 John Daniel Dobak, III Reduction of adipose tissue
KR102310519B1 (ko) * 2015-02-27 2021-10-08 (주)아모레퍼시픽 탄산가스 포집용 에어로졸 조성물
EP3296395B2 (en) 2015-05-13 2024-06-19 Chugai Seiyaku Kabushiki Kaisha Multiple antigen binding molecular fusion, pharmaceutical composition, method for identifying linear epitope, and method for preparing multiple antigen binding molecular fusion
PT3297605T (pt) 2015-05-21 2022-05-30 Dermavant Sciences GmbH Composições farmacêuticas tópicas
US11617724B2 (en) 2015-05-21 2023-04-04 Dermavant Sciences GmbH Topical pharmaceutical compositions
JP6997624B2 (ja) 2015-06-18 2022-01-17 ボシュ ヘルス ユーエス，エルエルシー． 乾癬を治療するためのコルチコステロイドおよびレチノイドを含む局所用組成物
WO2017011600A1 (en) 2015-07-13 2017-01-19 Dr. Reddy's Laboratories, Ltd. Topical retinoid compositions
WO2017049105A1 (en) * 2015-09-16 2017-03-23 Cidara Therapeutics, Inc. Formulations for treating fungal infections
FR3041538B1 (fr) * 2015-09-29 2018-11-30 Galderma Research & Development Mousse chimique non rincee contenant du propionate de clobetasol, et son utilisation dans le traitement du psoriasis.
EP3356027A4 (en) * 2015-09-30 2019-05-22 Nanovapor Inc. METHOD AND COMPOUNDS FOR STEAM SUPPRESSION
US10857159B2 (en) * 2015-12-15 2020-12-08 Mayne Pharma Llc Halobetasol foam composition and method of use thereof
CN108883152A (zh) 2016-01-08 2018-11-23 奇达拉治疗公司 防止和治疗肺孢子虫感染的方法
WO2017161016A1 (en) 2016-03-16 2017-09-21 Cidara Therapeutics, Inc. Dosing regimens for treatment of fungal infections
CA3020157C (en) * 2016-04-04 2024-01-16 Drug Delivery Solutions Limited Topical composition comprising tacrolimus
EP3468530A4 (en) 2016-06-10 2020-03-11 Clarity Cosmetics Inc. NON-COMEDOGEN FORMULA FOR HAIR AND SCALP CARE AND METHOD FOR USE
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases
US11197909B2 (en) 2017-07-12 2021-12-14 Cidara Therapeutics, Inc. Compositions and methods for the treatment of fungal infections
US10959975B1 (en) * 2017-11-02 2021-03-30 The Tetra Corporation Antifungal composition, method of making composition, and method of using composition
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
JP2021523230A (ja) * 2018-05-11 2021-09-02 フォーミュリティカ ピーティーワイ リミテッド サブミクロンエマルジョン
US11497718B2 (en) 2018-11-13 2022-11-15 Dermavant Sciences GmbH Use of tapinarof for the treatment of atopic dermatitis
FR3090342B1 (fr) * 2018-12-20 2021-05-21 Oreal Composition cosmétique capillaire sous forme de nanoémulsion comprenant un tensioactif non ionique particulier et un agent propulseur
WO2020152350A1 (en) * 2019-01-25 2020-07-30 Nogra Pharma Limited Compositions for use in preventing acne
KR102340804B1 (ko) * 2019-07-22 2021-12-17 주식회사 휴온스메디케어 클로르헥시딘 또는 이의 유도체를 포함하는 항균 지속성이 개선된 수용성 소독용 조성물 및 이를 포함하는 섬유형 소독제
CN111991404B (zh) * 2020-10-10 2021-08-13 西南医科大学 防治真菌感染的复合维生素d及其应用
EP4108234A1 (en) * 2021-06-25 2022-12-28 RaDes GmbH Topical pharmaceutical formulation
CN114796117A (zh) * 2022-05-24 2022-07-29 浙江大学 一种用于治疗银屑病的微乳泡沫剂及其制备方法

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026548A (en) * 1987-04-28 1991-06-25 Cadbury Schweppes Plc Surfactant
GB8813161D0 (en) * 1988-06-03 1988-07-06 Unilever Plc Emulsions
US6113921A (en) 1993-03-23 2000-09-05 Pharmos Corp. Topical and transdermal delivery system utilizing submicron oil spheres
US6461622B2 (en) * 1994-09-07 2002-10-08 Johnson & Johnson Consumer Companies, Inc. Topical compositions
DE19509079A1 (de) * 1995-03-15 1996-09-19 Beiersdorf Ag Kosmetische oder dermatologische Mikroemulsionen
FR2745716B1 (fr) * 1996-03-07 1998-04-17 Oreal Emulsions huile-dans-eau moussantes pressurisables ultrafines
US5744148A (en) * 1996-09-20 1998-04-28 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Stabilization of an unstable retinoid in oil-in-water emulsions for skin care compositions
US5968528A (en) * 1997-05-23 1999-10-19 The Procter & Gamble Company Skin care compositions
AUPP583198A0 (en) 1998-09-11 1998-10-01 Soltec Research Pty Ltd Mousse composition
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
US7115277B2 (en) 1999-03-04 2006-10-03 Allergan, Inc. Method for enabling delivery of an active agent
US6248354B1 (en) * 1999-03-04 2001-06-19 Allergan Sales, Inc. Capsule system
US20030003170A1 (en) 2000-06-02 2003-01-02 Theresa Callaghan Method for the topical treatment and prevention of inflammatory disorders and related conditions using extracts of feverfew (Tanacetum parthenium)
DE19938757A1 (de) * 1999-08-16 2001-02-22 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen vom Typ Öl-in-Wasser
US6358541B1 (en) 2000-05-03 2002-03-19 David S. Goodman Topical preparation for the treatment of hair loss
US6666133B2 (en) * 2001-04-11 2003-12-23 Lee W. Squyres Standing tree baler
DE10132003A1 (de) * 2001-07-03 2003-01-30 Merz & Co Gmbh & Co Fett(öl)haltiges Mittel, enthaltend Zwiebelextrakt, seine Herstellung und seine Verwendung zur Pflege, Vorbeugung oder Behandlung von geschädigtem Hautgewebe, insbesondere von Narben
FR2832311B1 (fr) 2001-11-21 2004-04-16 Besins Int Belgique Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20070292461A1 (en) 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20050205086A1 (en) * 2002-10-25 2005-09-22 Foamix Ltd. Retinoid immunomodulating kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US20060193789A1 (en) 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
US20080031907A1 (en) * 2002-10-25 2008-02-07 Foamix Ltd. Cosmetic and pharmaceutical foam
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
ES2637956T3 (es) * 2003-01-24 2017-10-18 Stiefel Research Australia Pty Ltd Espuma farmacéutica
US20040175347A1 (en) * 2003-03-04 2004-09-09 The Procter & Gamble Company Regulation of mammalian keratinous tissue using hexamidine compositions
ATE337003T1 (de) 2003-04-28 2006-09-15 Biofrontera Bioscience Gmbh Verwendung von riluzole kombiniert mit geeigneten hilfs-und zusatzstoffen zur behandlung von krankheiten, die durch eine hyperproliferation von keratinozyten gekennzeichnet sind, insbesondere neurodermitis und psoriasis
US20050014729A1 (en) 2003-07-16 2005-01-20 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
MXPA06001381A (es) 2003-08-04 2006-05-19 Foamix Ltd Vehiculo de espuma que contiene un gelificante copolimerico anfifilico.
EP2977043A3 (en) * 2003-08-25 2016-04-06 Foamix Pharmaceuticals Ltd. Penetrating pharmaceutical foam
ITMI20032019A1 (it) 2003-10-17 2005-04-18 Fidia Farmaceutici Microemulsioni di retinoidi e composizioni farmaceutiche che le contengono
US20050095215A1 (en) * 2003-11-03 2005-05-05 Popp Karl F. Antimicrobial shampoo compositions
JP4994039B2 (ja) 2003-11-26 2012-08-08 スパーナス ファーマシューティカルズ インコーポレイテッド 脂溶性または疎水性化合物の送達に有用なミセル系
EP1651199A4 (en) 2004-02-13 2008-08-20 Pcr Technology Holdings Lc PROCESS AND PREPARATION REDUCING IRRITATION AND / OR INFLAMMATORY SKIN REACTIONS IN HUMANS
US20050238597A1 (en) 2004-04-26 2005-10-27 Mccook John P Topical treatment of acne, seborrheic dermatitis, and oily skin with formulations containing histamine antagonists
US20070196453A1 (en) 2004-06-07 2007-08-23 Jie Zhang Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
US20070196323A1 (en) 2004-06-07 2007-08-23 Jie Zhang Polyvinyl alcohol-containing compositions and methods for dermal delivery of drugs
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US20070189977A1 (en) 2004-06-07 2007-08-16 Jie Zhang Spray-on formulations and methods for dermal delivery of drugs
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
AU2005279704B2 (en) 2004-08-31 2010-05-13 Stiefel Research Australia Pty Ltd Microemulsion and sub-micron emulsion process and compositions
CN101048136B (zh) * 2004-08-31 2011-06-22 施蒂福研究澳大利亚股份有限公司 微乳化和亚微米乳化方法和组合物
WO2006040644A2 (en) 2004-10-11 2006-04-20 Ranbaxy Laboratories Limited Processes for the preparation of substituted thiochroman derivatives
EP2526930B1 (en) * 2005-06-01 2013-12-25 GlaxoSmithKline Intellectual Property Development Limited Vitamin formulation
TW200711649A (en) 2005-06-17 2007-04-01 Combinatorx Inc Combination therapy for the treatment of immunoinflammatory disorders
AR054822A1 (es) * 2005-07-07 2007-07-18 Sanofi Pasteur Emulsion inmuno adyuvante
US9393218B2 (en) 2005-12-23 2016-07-19 Epinamics Gmbh Use of film-forming hair care polymers from the group of polyurethanes and pharmaceutical preparations and patches that contain these polymers
CA2633599C (en) 2005-12-23 2015-02-10 Epinamics Gmbh Use of film-forming hair-care polymers from the group of polyurethanes and pharmaceutical preparations and plasters containing said polymers
WO2007082864A2 (en) 2006-01-20 2007-07-26 Polichem Sa Use of chavicol as an antiseptic
US7252816B1 (en) 2006-03-29 2007-08-07 Dow Pharmaceutical Sciences Topical acne vulgairs medication with a sunscreen
WO2008075207A2 (en) 2006-04-04 2008-06-26 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US20070280972A1 (en) 2006-04-25 2007-12-06 Zars, Inc. Adhesive solid gel-forming formulations for dermal drug delivery
MXPA06008988A (es) 2006-08-08 2008-02-07 Fernando Ahumada Ayala Preparaciones topicas antiacne que contienen retinoide (tazaroteno o adapaleno), antibiotico (fosfato de clindamicina) y/o queratolitico (peroxido de bonzoilo en microesponjas).
US20100076037A1 (en) 2006-11-02 2010-03-25 Chiang Lillian W Methods of Treating Neuropathic Pain with Agonists of PPAR-gamma
EP2097065A2 (en) 2006-11-29 2009-09-09 Foamix Ltd. Foamable waterless compositions with modulating agents
EP1958613A1 (en) 2007-02-15 2008-08-20 Polichem S.A. Dermal film-forming liquid formulations for drug release to skin
DE102007059703A1 (de) 2007-02-28 2008-09-04 Henkel Ag & Co. Kgaa Wirkstoff-stabiliserte O/W-Emulsionen II
DE102007059704A1 (de) 2007-02-28 2008-09-04 Henkel Ag & Co. Kgaa Reinigende O/W-Emulsion
FR2915682B1 (fr) 2007-05-04 2009-07-03 Galderma Res & Dev Compositions depigmentantes dermatologiques et cosmetiques, leurs procedes de preparation, et leurs utilisations
US8636982B2 (en) * 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
JP5946990B2 (ja) 2007-08-29 2016-07-06 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 化粧品及び医薬品使用のための精油を含有する糖系界面活性剤マイクロエマルジョン
PT2400951T (pt) * 2009-02-25 2018-11-26 Mayne Pharma Llc Composições de espuma tópica
EP2272495A1 (en) * 2009-07-08 2011-01-12 KPSS-Kao Professional Salon Services GmbH Composition and method for levelling hair colour
US20120053251A1 (en) * 2010-09-01 2012-03-01 Antioxidant Superfoods, Inc. Fat emulsion providing improved health and taste characteristics in food

Also Published As

Publication number Publication date
ZA201105769B (en) 2012-04-25
US20100221194A1 (en) 2010-09-02
BRPI1008037B1 (pt) 2019-08-06
ES2696989T3 (es) 2019-01-21
US20200352892A1 (en) 2020-11-12
US10688071B2 (en) 2020-06-23
PL2400951T3 (pl) 2019-02-28
US10568859B2 (en) 2020-02-25
KR20110138353A (ko) 2011-12-27
US8808716B2 (en) 2014-08-19
MX2011008912A (es) 2011-09-09
CA2753497A1 (en) 2010-09-02
EA201171079A1 (ru) 2012-03-30
MX340791B (es) 2016-07-25
JP2016040291A (ja) 2016-03-24
EP2400951A1 (en) 2012-01-04
PT2400951T (pt) 2018-11-26
CN102438590A (zh) 2012-05-02
SG173563A1 (en) 2011-09-29
KR101725196B1 (ko) 2017-04-10
CL2011002053A1 (es) 2012-02-24
CN102438590B (zh) 2013-07-10
WO2010096868A1 (en) 2010-09-02
EP2400951B1 (en) 2018-08-15
AU2010217190B2 (en) 2012-10-25
US20130011452A1 (en) 2013-01-10
IL214520A (en) 2014-12-31
IL214520A0 (en) 2011-09-27
JP6130992B2 (ja) 2017-05-17
AU2010217190A1 (en) 2011-09-22
CA2753497C (en) 2016-07-05
JP2012518662A (ja) 2012-08-16
DK2400951T3 (en) 2018-12-03
JP6182191B2 (ja) 2017-08-16
US20130005774A1 (en) 2013-01-03
EP2400951A4 (en) 2012-08-15
EA020844B1 (ru) 2015-02-27

Similar Documents

Publication Publication Date Title
BRPI1008037A2 (pt) composição de espuma tópica
SMT201600307B (it) Composizione liposomiale
BRPI1013588A2 (pt) composição
BRPI1009281A2 (pt) composição oftálmica tópica
BRPI1015474A2 (pt) composição
SMT201500053B (it) 2-Amminobenzimidazol-5-carbossammidi come agenti nati-infiammatori
BR112013014614A2 (pt) misturas de glicosídeo
DK3078664T3 (da) Antiparasitiske dihydroazol-sammensætninger
EP2488022A4 (en) Compositions
BRPI1013335A2 (pt) composição compósita
UY33161A (es) Composiciones plaguicidas
GB0913255D0 (en) Topical composition
BR112012000528A2 (pt) composição antifúngica tópica
ZA201204018B (en) Topical foam composition
BRPI1006632A2 (pt) composição catalisadora
BRPI1010690A2 (pt) composições
BRPI1009465A2 (pt) Formulação
EP2478768A4 (en) AGGREGATE AGAINST PLANT VIRUSES
PT2635269T (pt) Composição de combinação
ZA201204017B (en) Topical foam composition
EP2479211A4 (en) FLUOR RUBBER COMPOSITION
BRPI1005318A2 (pt) composição
BR112012015386A2 (pt) composição oftálmica tópica
EP2413905A4 (en) FORMULATION
EP2603559A4 (en) POLYISOCYANURATZUSAMMENSETZUNG

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08G Application fees: restoration [chapter 8.7 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/02/2010, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/02/2010, OBSERVADAS AS CONDICOES LEGAIS

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 10A ANUIDADE.

B24D Patent annual fee: restoration after fee payment
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 13A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2711 DE 20-12-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.